Skip to main content
All lobbying filings

B HALL STRATEGIES, LLC

Lobbying for TIBER CREEK GROUP ON BEHALF OF JAZZ PHARMACEUTICALS · Biopharmaceutical company.

 Filing Registration
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · posted Jul 15, 2025

Official filing document

 Lobbying activity 3
Health Issues

Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp; Issues related to cannabis research; Appropriations issues related to House Ag/FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products.

Budget/Appropriations

Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp; Issues related to cannabis research; Appropriations issues related to House Ag/FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products.

Medical/Disease Research/Clinical Labs

Issues related to the FDA and Health and Human Services pertaining to CBD policies; Issues related to the regulation of intoxifying hemp; Issues related to cannabis research; Appropriations issues related to House Ag/FDA Appropriations bill pertaining to FDA enforcement of non-FDA approved, cannabis derived CBD products.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem